Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bio-Rad Laboratories
(NY:
BIO
)
368.92
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2
Open
368.92
Bid (Size)
147.57 (2)
Ask (Size)
586.58 (1)
Prev. Close
368.92
Today's Range
368.92 - 368.92
52wk Range
262.12 - 372.27
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Bio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare Conference
October 31, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Third-Quarter 2024 Financial Results
October 30, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Performance
YTD
+12.48%
+12.48%
1 Month
+8.18%
+8.18%
3 Month
+12.24%
+12.24%
6 Month
+30.84%
+30.84%
1 Year
+27.72%
+27.72%
More News
Read More
Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024
October 14, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Expert Ratings For Bio-Rad Laboratories
October 01, 2024
Via
Benzinga
Triple-Witch Says, “Remember Me?”
September 20, 2024
Via
Talk Markets
The Analyst Landscape: 4 Takes On Bio-Rad Laboratories
May 08, 2024
Via
Benzinga
S&P 500 Shake-Up: New Entrants Driving Market Momentum
September 24, 2024
Via
MarketBeat
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Palantir Stock Will Join the S&P 500 in September. History Says It Could Soar Afterward.
September 13, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Palantir Stock Soars After S&P 500 Inclusion, AI Deal With BP Fuels Additional Gains – What's Next?
September 09, 2024
Via
Benzinga
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Palantir, Dell Will Join The S&P 500. The AI Stocks Are Jumping.
September 06, 2024
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Bio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare Conference
August 22, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer
August 20, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Second-Quarter 2024 Financial Results
August 01, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024
July 17, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
S&P 500 Ends First Half Shy Of All-Time Highs. Here Are The Leaders And Laggards — And 5 Stocks That Could Outperform In Next 6 Months
June 30, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via
AB Newswire
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via
TheNewswire.com
Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group
May 30, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference
May 23, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
BIO Stock Earnings: Bio-Rad Laboratories Beats EPS, Misses Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Bio-Rad Reports First-Quarter 2024 Financial Results
May 07, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
May 01, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Announces Life Science Group Management Changes
April 26, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?
April 18, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
April 18, 2024
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.